The European Drug Safety Summit 2018 taking place in London on 17th & 18th October will bring together pharmacovigilance personnel from key pharmaceutical companies to address the challenges in monitoring and maintaining drug safety strategies.

The two day event will discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.